A 31-year-old man presents to the emergency department with a 5-week history of productive cough, low-grade fever, drenching night sweats, and a -kg (-lb) weight loss. He emigrated from an area with high tuberculosis prevalence three years ago and currently resides in a crowded apartment. His temperature is C ( F), blood pressure is mm Hg, pulse is /min, and respirations are /min. Oxygen saturation is on room air. Pulmonary examination reveals bronchial breath sounds and crackles in the right upper lung field. A chest radiograph demonstrates a cavitary infiltrate in the right upper lobe.
Arrange the following interventions in the most appropriate chronological order for the management of this patient.
- 1Place the patient in a negative-pressure airborne infection isolation room
- 2Collect sputum specimens for acid-fast bacilli (AFB) smear, culture, and nucleic acid amplification testing
- 3Initiate intensive phase therapy with isoniazid, rifampin, pyrazinamide, and ethambutol
- 4De-escalate to continuation phase therapy with isoniazid and rifampin
Cevap
The correct management sequence is: 1) Place the patient in a negative-pressure airborne infection isolation room, 2) Collect sputum specimens for AFB smear and culture, 3) Initiate intensive phase therapy with a 4-drug regimen, and 4) De-escalate to a 2-drug continuation phase therapy.
The correct chronological order for managing a patient with highly suspected active pulmonary tuberculosis begins with immediate airborne isolation, followed by diagnostic sampling, initiation of empiric multi-drug therapy, and finally, targeted de-escalation. Immediate placement in a negative-pressure airborne infection isolation room is the critical first step to prevent nosocomial transmission. Once the patient is isolated, diagnostic sputum specimens must be collected before administering any antimicrobials, as therapy can rapidly render cultures negative and preclude necessary drug susceptibility testing. Following specimen collection, standard intensive phase therapy with a 4-drug regimen (isoniazid, rifampin, pyrazinamide, and ethambutol) is initiated to quickly decrease the mycobacterial burden. After completing 2 months of this intensive phase and confirming organism susceptibility, the regimen is de-escalated to a 2-drug continuation phase (isoniazid and rifampin) for an additional 4 months to achieve a definitive cure.
Adım Adım Çözüm
Anahtar Kavram
Management sequence of active pulmonary tuberculosis: Airborne isolation, followed by diagnostic specimen collection, initiation of 4-drug intensive therapy, and subsequent de-escalation to 2-drug continuation therapy.